Insider Trading June 2, 2026 09:07 PM

Ondas CEO Sells Stock After RSU Vesting; Company Secures Major Contracts

Eric Brock divests $31.9 million worth of shares following vesting, while Ondas reports significant contract wins and corporate filings related to acquisitions.

By Marcus Reed ONDS

Chairman, CEO, and President Eric A. Brock sold company stock valued at approximately $31.9 million over two days in June 2026. This disposition was linked to tax withholding obligations associated with the vesting of his Restricted Stock Units (RSUs). Meanwhile, Ondas Inc. reported securing substantial new orders totaling over $110 million for the second quarter and announced a contract win for its subsidiary, World View Enterprises.

Ondas CEO Sells Stock After RSU Vesting; Company Secures Major Contracts
ONDS

Key Points

  • The company secured robust contract activity in the second quarter, totaling over $110 million, with specific contracts covering critical defense technologies like air defense and counter-unmanned aircraft systems.
  • World View Enterprises secured a specialized $4.8 million contract for high-altitude balloon systems supporting U.S. Naval Forces' Maritime Domain Awareness mission across the Eastern Pacific and Caribbean.

Eric A. Brock, who serves as Chairman, CEO, and President of Ondas Inc. (NASDAQ:ONDS), recently executed transactions involving company shares valued at roughly $31.9 million, according to disclosures filed with the SEC on Form 4.

The reported activity took place across two dates in early June 2026, specifically June 1 and June 2. On June 2, Mr. Brock sold a total of 2,378,245 shares of Ondas common stock at a price point of $13.43 per share. This disposition resulted in proceeds totaling approximately $31.9 million.

The sale was structured to cover potential tax withholding obligations that arose concurrently with the vesting of Mr. Brock’s Restricted Stock Units (RSUs). The preceding day, June 1, marked a different type of transaction: Mr. Brock acquired 4,500,000 shares of Ondas common stock. These shares were received upon the vesting of RSUs and had an acquisition cost of $0.

Following these reported transactions, internal records indicate that Mr. Brock directly maintains ownership of 3,583,010 shares of Ondas common stock. His holdings are further diversified through Privet Ventures LLC, an investment company under his ownership, which holds an additional 1,153,625 shares.


The timing of the sale occurs while Ondas shares trade at $13.58. This current trading level is near the stock's 52-week high of $15.28, following a substantial gain of 856% over the past year. Furthermore, analysis provided by InvestingPro suggests that the stock may currently be considered overvalued when measured against its Fair Value, placing it within categories for potential consideration on the Most Overvalued list.


The underlying structure of Mr. Brock's equity grants was detailed in recent filings. Specifically, he was initially granted 13,500,000 RSUs on February 11, 2026. A portion of this grant, amounting to 4,500,000 shares, vested on June 1, 2026. The remaining balance of 9,000,000 RSUs is scheduled to vest in subsequent tranches spanning from March 2027 through March 2029. This future vesting remains contingent upon Mr. Brock continuing his role as an officer of the company on the respective vesting dates.


Beyond the executive transactions, Ondas Inc. has reported significant operational achievements. During May alone, the company announced securing over $30 million in new orders. Cumulatively, these figures contribute to a total order value exceeding $110 million recorded for the second quarter. These substantial contracts cover diverse defense technology areas, including air defense systems, counter-unmanned aircraft systems, loitering munitions, and intelligence, surveillance, and reconnaissance (ISR) systems.

In separate corporate news, Ondas’ subsidiary, World View Enterprises, was awarded a contract valued at $4.8 million. This agreement involves providing high-altitude balloon systems for a Maritime Domain Awareness program. Said program supports U.S. Naval Forces' efforts in conducting missions related to counter-narcotics and illegal fishing across the Eastern Pacific and Caribbean regions.


From a corporate development standpoint, Ondas submitted a prospectus supplement to the U.S. Securities and Exchange Commission (SEC). This filing pertains to the potential resale of shares linked to its acquisitions of both World View Enterprises and Mistral, Inc. The filings address 297 shares associated with World View and 2,738,224 shares related to Mistral. These particular shares were issued to stockholders as part of their respective acquisitions and were exempt from registration under the Securities Act of 1933.

The company's stock experienced a rise alongside other U.S. drone manufacturers following reports concerning potential Pentagon funding talks, indicating sector-wide attention.


Market Analysis and Key Takeaways

From an analyst perspective tracking corporate activity, the combination of executive selling and strong contract wins provides several points for consideration regarding internal confidence and market valuation perceptions. The reported sales by Mr. Brock suggest a mechanism to manage tax liabilities related to equity vesting, which is a standard financial procedure following significant RSU grants.

Risks

  • The current stock valuation, as noted by InvestingPro analysis, suggests the stock may be overvalued relative to its Fair Value, which represents a potential risk factor for investors.
  • Future RSU vesting amounts are explicitly contingent upon Mr. Brock remaining in his officer role through 2029, introducing key-person dependency and retention risks.

More from Insider Trading

Rackspace Technology Executive Offloads Shares to Cover Tax Obligations Amid Stock Surge Jun 4, 2026 Fermi Inc. Executive Unloads $1M in Shares Amid Ongoing Corporate Restructuring Jun 4, 2026 Veracyte Executive Sells Nearly $700K in Shares Amid Product Rollouts and Analyst Upgrades Jun 4, 2026 Veracyte Executive Traces Share Disposition Amid Clinical Milestones and Valuation Scrutiny Jun 4, 2026 Veracyte CFO Executes $177K Stock Sale Amid Clinical Trial Updates and Analyst Revisions Jun 4, 2026